Moreover, a recent study has showed that serum CK19 levels, associated to AFP and PIVKA-II, may be useful to stratify survival of patients with HCC in Patients with Hepatocellular Carcinoma [18], highlighting the importance of CK19 as a prognostic marker. Here, KRT19 is linked to hepatocellular carcinoma.